Anzeige
Mehr »
Login
Freitag, 25.10.2024 Börsentäglich über 12.000 News von 675 internationalen Medien
Warum diese Minenaktie Ihre beste Absicherung gegen wirtschaftliches Chaos sein könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 931236 | ISIN: SE0000421273 | Ticker-Symbol: KOW
Frankfurt
25.10.24
08:18 Uhr
12,680 Euro
0,000
0,00 %
Branche
IT-Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
KNOWIT AB Chart 1 Jahr
5-Tage-Chart
KNOWIT AB 5-Tage-Chart
GlobeNewswire (Europe)
26 Leser
Artikel bewerten:
(0)

Know IT AB: Slow recovery

The third quarter of the year was characterized by varied demand across different segments and geographic areas, where Knowit is facing its greatest demands in the Swedish market. After over a year of hard work to optimize and strengthen the organization, we are seeing that the negative development has partially stopped and that utilization is slowly improving. This applies primarily to our largest business area Solutions. At the same time, we and our entire sector continue to be challenged by weak demand and a relatively unpredictable market. The nest sales for the quarter decreased by 14.1 percent, combined with an adjusted EBITA margin of 4.4 percent. Net sales were SEK 1,326.2 (1,544.1) million and the adjusted EBITA profit was SEK 57.9 (74.9) million.

"It is still too early to say that we are seeing any general recovery or that we have reached the bottom of the recession. Demand varies across segments and geographic areas, which it has throughout the past year. In our largest business areas, Solutions, we are seeing that the early signs of recovery which we noted already during the second quarter have continued throughout the third quarter. For the second quarter running we have seen a modest, but positive, trend as regards utilization," says Per Wallentin, CEO and President.

Proactivity in client dialogues, combined with a focus on constant improvements to our internal efficiency, continues to be a guiding star in the organization. Companies and authorities have a large need to continue their digitalization journey in a weaker economy too.

"The significance of innovation and new technology is increasing in society, even during a recession. As one of the leading suppliers in the Nordic region, Knowit is well-positioned to start growing again and gaining market shares when the market does pivot. Through the actions taken during the last year, we are well-equipped to face a higher demand on a stronger market.," says Per Wallentin.

For more detailed information on the results for the second quarter, please see the interim report available on Knowit's website and appended this press release.

Presentation of Interim Report

Knowit will be holding a presentation of the Interim Report today, Friday October 25. President and CEO Per Wallentin and CFO Marie Björklund comment on the results and answer questions.

The report will be available at https://www.knowit.eu/financial-information/

The presentation starts at 10.00 am (CEST) and will be held in English.

Link to the audiocast: https://www.investis-live.com/knowit/66ffbab6b2cedb000e38cb4c/pandg

Telephone numbers to the audiocast:

Sweden +46 8 5051 0031
United Kingdom +44 207 107 06 13

Other international numbers are available HERE

Pin: 43405119

No advance notification is necessary. After the presentation, a recording of the webcast will be available at https://www.knowit.eu/financial-information/

The information contained herein is such as shall be made public by Knowit, in accordance with the EU Market Abuse Regulation. This press release was made public through the agency of President and CEO Per Wallentin, at 7:30 AM CEST on October 25, 2024.

For more information, please contact:
Marie Björklund, CFO, +46(0)8 700 66 00 or marie.bjorklund@knowit.se
Christina Johansson, Head of Communications, +46(0)70 542 1734 or christina.johansson@knowit.se
Annika Billberg, Investor Relations, +46(0)70 267 97 91 0rt annika.billberg@knowit.se

About Knowit
Knowit are digitalization consultants and a Nordic powerhouse for the digital business models of the future. Our vision is to create a sustainable and humane society through digitalization and innovation. Knowit supports its clients in the digital transformation and stands out among other consultancy firms through its decentralized organization and agile work methods in client assignments. The operations are divided into four business areas - Solutions, Experience, Connectivity, and Insight - which offer services in bespoke system development, digital customer experiences, the internet of things, cloud, cybersecurity, and management consultancy. Competences from several business areas are often combined in client projects.

Knowit was founded in 1990 and now has around 3,950 employees, mainly in the Nordic countries, but also in operations in Germany and Poland. Knowit AB (publ) has been listed on the stock market since 1997 and is currently listed on Nasdaq OMX Stockholm Mid Cap. For more information about Knowit, please visit knowit.eu.


© 2024 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.